Abstract
Continuous administration of VEGFA antibody upregulates SERPINE1/PAI-1 expression via the downregulation of miR-143-3p, which contributes to acquiring bevacizumab resistance in ovarian cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have